ContraFect Corporation
CFRX
CFRX was delisted on the 8th of November, 2023.
9 hedge funds and large institutions have $4.46M invested in ContraFect Corporation in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.
202% more capital invested
Capital invested by funds: $1.48M → $4.46M (+$2.98M)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
29% more funds holding
Funds holding: 7 → 9 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.22M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$396K |
| 3 |
LPC
Loeb Partners Corp
New York
|
+$156K |
| 4 |
SIM
Spark Investment Management
New York
|
+$134K |
| 5 |
Morgan Stanley
New York
|
+$47.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$7.27K |
CFRX Hedge Fund Activity: Q1 2015 in Review
9 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in ContraFect Corporation (CFRX) for Q1 2015, worth a combined $4.46M — up 202% from $1.48M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CFRX positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $1.22M. The largest seller was UBS Group, exiting entirely with an estimated $7.27K sold.
- 9 institutional investors held ContraFect Corporation (CFRX) as of Q1 2015, up from 7 in Q4 2014.
- Funds reported $4.46M of ContraFect Corporation stock for Q1 2015, up 202% quarter-over-quarter.
- 3 funds opened new ContraFect Corporation positions in Q1 2015 and 1 closed out, a net change of +2 holders.
- The largest ContraFect Corporation buyer in Q1 2015 was Vanguard Group, an estimated $1.22M added.
- The largest ContraFect Corporation seller in Q1 2015 was UBS Group, an estimated $7.27K sold.
Based on aggregated 13F filings for Q1 2015.